IR meeting with analysts and investors with Julie Kim, President of Takeda's Plasma-Derived Therapies Business Unit (Held on October 10, 2019)

FY2019 Q2 Financial Results Announcement (3:00pm JST on October 31^st, 2019)
Meeting: For Media: 4:15pm-5:15pm JST / For Investors & Analysts: 5:45pm-7:00pm JST
(Presenters: Christophe Weber, President & CEO, and others)
Conference Call: 9:00pm-9:45pm JST

Takeda Announces NATPARA^® Special Use Program in the US (September 25, 2019)

Offer for Shire plc

ADS Helpline